DREAM Antibodies

Santa Cruz Biotechnology features a diverse variety of DREAM Antibodies for studying the downstream regulatory element antagonist modulator (DREAM) protein. DREAM Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The downstream regulatory element antagonist modulator (DREAM) protein plays a crucial role in regulating gene expression and cellular responses to stress. DREAM is involved in processes such as neuronal differentiation and the modulation of pain pathways, making it significant in both neurobiology and pain research. Understanding downstream regulatory element antagonist modulator (DREAM) can provide insights into various physiological and pathological conditions. Researchers worldwide rely on downstream regulatory element antagonist modulator (DREAM) studies to explore potential therapeutic targets for neurological disorders. Current investigations focus on how DREAM influences calcium signaling pathways and transcriptional regulation. Ongoing research continues to reveal new functions of DREAM in different cellular processes. Santa Cruz Biotechnology monoclonal antibodies for downstream regulatory element antagonist modulator (DREAM) support researchers in advancing scientific understanding of neurological conditions and pain management strategies.